Douglas Williams, Ph.D., will leave Biogen at the end of July to become CEO of as-yet unnamed start-up biotechnology company. Dr. Williams will be the first member of a new organization with potential in cancer diagnostics and therapy. Responsibility for Biogen Research and Development will be assumed by Alfred Sandrock, M.D., Ph.D., senior vice president […]
News: Douglas Williams Leaving Biogen $BIIB Read More »
RXi Pharmaceuticals., has announced its first quarter results for FY-2015. The results shows revenues of $34,000 up by +17.2% and Loss Per Share -$0.13 improves by 59.4% YoY. View the full earnings release here.
RXi Improves Losses $RXII $XHS Read More »
ICON plc, a global provider of pharmaceutical, biotechnology and medical devices, , has announced its financial results for the first quarter 2015. The results shows Revenues Rise to $388.2 Million at +11.0% and EPS was $0.9 up by +57.9%. View the full earnings release here.
Icon Revenues Up $ICLR $XHS Read More »
Biogen Inc. has announced its first quarter results for FY-2015. The Results shows the following:- Quarterly Revenues up by 20% now at $2.6 Billion, EPS was $3.49 up by 73% Y/Y. View the full earnings release here.
Biogen Earnings on Rise $BIIB $XHS Read More »
Sinovac Biotech has announced its annual financial results of FY-14. The results Shows that Sales downs 13%, Gross Profit down 9.1% and Net Income (EPS) of $0.13 went down to Loss at -$0.02. View the full earnings release here.
Sinovac Revenues Down $SVA $XHS Read More »
